These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29778277)

  • 61. [Correlation between genotypes and phenotypes in pseudohypertrophic muscular dystrophy].
    Feng SW; Liang YY; Cao JQ; Song XM; Zhang C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):653-7. PubMed ID: 23225043
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy.
    Hoogerwaard EM; Ginjaar IB; Bakker E; de Visser M
    Neurology; 2005 Dec; 65(12):1984-6. PubMed ID: 16380627
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Coexistence of a CAV3 mutation and a DMD deletion in a family with complex muscular diseases.
    Hiraide T; Ogata T; Watanabe S; Nakashima M; Fukuda T; Saitsu H
    Brain Dev; 2019 May; 41(5):474-479. PubMed ID: 30723005
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prevalence and Genetic Profile of Duchene and Becker Muscular Dystrophy in Puerto Rico.
    Ramos E; Conde JG; Berrios RA; Pardo S; Gómez O; Mas Rodríguez MF
    J Neuromuscul Dis; 2016 May; 3(2):261-266. PubMed ID: 27854217
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Dystrophin detection by immunofluorescent technique for diagnosing muscular dystrophy].
    Wang X; Xie Y; Zhang C; Liu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):239-42. PubMed ID: 12048687
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A
    Yu H; Chen YC; Liu GL; Wu ZY
    Chin Med J (Engl); 2017 Oct; 130(19):2273-2278. PubMed ID: 28937030
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A rare subclinical or mild type of Becker muscular dystrophy caused by a single exon 48 deletion of the dystrophin gene.
    Zimowski JG; Pilch J; Pawelec M; Purzycka JK; Kubalska J; Ziora-Jakutowicz K; Dudzińska M; Zaremba J
    J Appl Genet; 2017 Aug; 58(3):343-347. PubMed ID: 28247318
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy.
    Miyatake S; Mizobe Y; Takizawa H; Hara Y; Yokota T; Takeda S; Aoki Y
    Methods Mol Biol; 2018; 1687():123-141. PubMed ID: 29067660
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Analysis of dystrophin mRNA from skeletal muscle but not from lymphocytes led to identification of a novel nonsense mutation in a carrier of Duchenne muscular dystrophy.
    Ito T; Takeshima Y; Yagi M; Kamei S; Wada H; Nakamura H; Matsuo M
    J Neurol; 2003 May; 250(5):581-7. PubMed ID: 12736738
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Genetic diagnosis of Duchenne/Becker muscular dystrophy by MLPA].
    Zhang Y; Liu X; He R; Ma H; Zhao Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Jun; 31(3):338-43. PubMed ID: 24928015
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Genotype, phenotype analysis and follow-up study on patients with Duchenne/Becker muscular dystrophy].
    Zhang YZ; Xiong H; Wang XZ; Wang S; Luo J; Wang JM; Jiang YW; Chang XZ; Pan H; Qi JG; Li WZ; Yuan Y; Wu XR
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Dec; 42(6):661-6. PubMed ID: 21170096
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Remarkably low fibroblast acid α-glucosidase activity in three adults with Pompe disease.
    Wens SC; Kroos MA; de Vries JM; Hoogeveen-Westerveld M; Wijgerde MG; van Doorn PA; van der Ploeg AT; Reuser AJ
    Mol Genet Metab; 2012 Nov; 107(3):485-9. PubMed ID: 23000108
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Four siblings with becker muscular dystrophy (BMD) manifesting severe mental retardation].
    Futamura N; Kawamoto K; Takahashi K; Funakawa I; Jinnai K
    Rinsho Shinkeigaku; 2006 Jan; 46(1):62-5. PubMed ID: 16541798
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Point mutation and polymorphism in Duchenne/Becker muscular dystrophy (D/BMD) patients.
    Chaturvedi LS; Mukherjee M; Srivastava S; Mittal RD; Mittal B
    Exp Mol Med; 2001 Dec; 33(4):251-6. PubMed ID: 11795488
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls.
    Janssen B; Hartmann C; Scholz V; Jauch A; Zschocke J
    Neurogenetics; 2005 Feb; 6(1):29-35. PubMed ID: 15655674
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Novel deletion at the M and P promoters of the human dystrophin gene associated with a Duchenne muscular dystrophy.
    Frisso G; Sampaolo S; Pastore L; Carlomagno A; Calise RM; Di Iorio G; Salvatore F
    Neuromuscul Disord; 2002 Jun; 12(5):494-7. PubMed ID: 12031623
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Becker muscular dystrophy in a patient with Hodgkin's disease.
    Cereda S; Cefalo G; Terenziani M; Catania S; Fossati-Bellani F
    J Pediatr Hematol Oncol; 2004 Jan; 26(1):72-3. PubMed ID: 14707720
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Unusual presentation as an adult onset painful myopathy in a Thai patient with Becker muscular dystrophy.
    Pithukpakorn M
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S250-2. PubMed ID: 21721455
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy.
    Zatz M; Rapaport D; Vainzof M; Passos-Bueno MR; Bortolini ER; Pavanello Rde C; Peres CA
    J Neurol Sci; 1991 Apr; 102(2):190-6. PubMed ID: 2072118
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Kidney involvement and associated risk factors in children with Duchenne muscular dystrophy.
    Kutluk MG; Doğan ÇS
    Pediatr Nephrol; 2020 Oct; 35(10):1953-1958. PubMed ID: 32447503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.